Related Experiment Video
Updated: Aug 11, 2026
06:41
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Methionine metabolism and phenotypic variability in X-linked adrenoleukodystrophy
M Linnebank1, S Kemp, R J A Wanders
1Department of Neurology, University Hospital Bonn, Bonn, Germany. michael.linnebank@ukb.uni-bonn.de
Neurology
|February 16, 2006
Summary
Methionine metabolism gene variants are linked to central nervous system demyelination in X-linked adrenoleukodystrophy patients. This suggests a role for methionine metabolism in the varied clinical presentations of this genetic disorder.
Area of Science:
- Genetics
- Neurology
- Metabolic disorders
Background:
- X-linked adrenoleukodystrophy (X-ALD) is a rare genetic disorder characterized by the breakdown of myelin in the nervous system.
- Phenotypic variability in X-ALD, particularly the development of central nervous system (CNS) demyelination in adrenomyeloneuropathy (AMN), is not fully understood.
- Methotrexate treatment in other conditions has been associated with CNS demyelination linked to specific genetic polymorphisms.
Purpose of the Study:
- To investigate the association between polymorphisms in methionine metabolism genes and the occurrence of CNS demyelination in patients with X-ALD.
- To explore the potential contribution of methionine metabolism to the phenotypic variability observed in X-ALD, specifically in the context of AMN.
Main Methods:
- Genotyping of a combined polymorphism in methionine metabolism pathways was performed.
- A cohort of 86 patients with X-linked adrenoleukodystrophy was analyzed.
- Patients were categorized into subgroups based on the presence or absence of CNS demyelination within the adrenomyeloneuropathy phenotype.
Main Results:
- A specific combined genotype related to methionine metabolism was found to be significantly overrepresented in AMN patients with CNS demyelination compared to those without CNS demyelination (p = 0.002).
- This genotype was observed in 15 out of 86 X-ALD patients presenting with AMN and CNS demyelination.
- The control group consisted of 49 AMN patients without CNS demyelination ('pure' AMN).
Conclusions:
- The findings suggest that specific genetic variations in methionine metabolism pathways may play a role in the development of CNS demyelination in X-ALD.
- Methionine metabolism could be a contributing factor to the diverse clinical outcomes and phenotypic variability seen in X-linked adrenoleukodystrophy.
- Further research into metabolic pathways may offer insights into targeted therapies for X-ALD.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:43Sex-linked Disorders
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...